SynthesisCurrent oncology (Toronto, Ont.)2024

Venous Thromboembolism Risk in Hematological Malignancies Post-Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: A Meta-Analysis of Phase 2 and Phase 3 Clinical Trials.

Akshit Chitkara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.